Andrews Deborah J

Chief Financial Officer | Director | Vice President

2 companies

Andrews Deborah J is a Chief Financial Officer at Lineage Cell Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 8 sells.

Estimated insider holdings value: $882K based on current market prices.

Holdings by Company

LCTXJun 29, 2021

Current Shares34.7K

Value$47.6K

Net Activity-9,142

Bought: 10.0KSold: 19.1K

STAAMar 23, 2020

Current Shares31.3K

Value$834.5K

Net Activity-127,102

Bought: 0Sold: 127.1K

Transaction History

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 29, 2021	LCTX Lineage Cell Therapeutics, Inc.	-	Sale+OE	19,142	$2.93	$56,086.06	-55.1%	-8.9%	-45.1%
Mar 23, 2020	STAA Staar Surgical Co	Chief Financial Officer	Sell	834	$27.42	$22,868.28	-2.6%	-	-
Jan 21, 2020	STAA Staar Surgical Co	Chief Financial Officer	Sale+OE	106,604	$42.20	$4,498,688.80	-76.9%	-	-
Nov 14, 2019	STAA Staar Surgical Co	Chief Financial Officer	Sell	4,167	$34.68	$144,511.56	-11.5%	-	-
Apr 4, 2019	STAA Staar Surgical Co	Chief Financial Officer	Sell	1,000	$34.35	$34,350.00	-2.7%	-	-
Mar 22, 2019	STAA Staar Surgical Co	Chief Financial Officer	Sell	833	$38.88	$32,387.04	-2.2%	-	-
Sep 11, 2018	LCTX Lineage Cell Therapeutics, Inc.	Director	Buy	1,604	$2.35	$3,769.40	+19.1%	-	-
May 3, 2018	STAA Staar Surgical Co	Chief Financial Officer	Sale+OE	13,331	$17.60	$234,625.60	-46.0%	-	-
Mar 22, 2018	STAA Staar Surgical Co	Chief Financial Officer	Sell	333	$16.05	$5,344.65	-2.1%	-	-
Aug 21, 2017	LCTX Lineage Cell Therapeutics, Inc.	Director	Buy	2,396	$2.50	$5,990.00	+39.9%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC